These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

700 related items for PubMed ID: 8421902

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Chimeric HIV-1 virus-like particles containing gp120 epitopes as a result of a ribosomal frameshift elicit Gag- and SU-specific murine cytotoxic T-lymphocyte activities.
    Tobin GJ, Li GH, Fong SE, Nagashima K, Gonda MA.
    Virology; 1997 Sep 29; 236(2):307-15. PubMed ID: 9325238
    [Abstract] [Full Text] [Related]

  • 6. A human cell line constitutively expressing HIV-1 Gag and Gag-Pol gene products.
    Wang CT, Li JJ, Lai HY, Hu BS.
    J Med Virol; 1999 Jan 29; 57(1):17-24. PubMed ID: 9890417
    [Abstract] [Full Text] [Related]

  • 7. Assembly of the matrix protein of simian immunodeficiency virus into virus-like particles.
    González SA, Affranchino JL, Gelderblom HR, Burny A.
    Virology; 1993 Jun 29; 194(2):548-56. PubMed ID: 8503172
    [Abstract] [Full Text] [Related]

  • 8. Characterization of human immunodeficiency virus type 1 Pr160 gag-pol mutants with truncations downstream of the protease domain.
    Liao WH, Wang CT.
    Virology; 2004 Nov 10; 329(1):180-8. PubMed ID: 15476885
    [Abstract] [Full Text] [Related]

  • 9. Expression of human immunodeficiency virus type 1 Gag protein precursor and envelope proteins from a vesicular stomatitis virus recombinant: high-level production of virus-like particles containing HIV envelope.
    Haglund K, Forman J, Kräusslich HG, Rose JK.
    Virology; 2000 Mar 01; 268(1):112-21. PubMed ID: 10683333
    [Abstract] [Full Text] [Related]

  • 10. Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens.
    Kmieciak D, Bolesta E, Naito T, Gzyl J, Kaneko Y, Kozbor D.
    J Hum Virol; 2001 Mar 01; 4(6):306-16. PubMed ID: 12082397
    [Abstract] [Full Text] [Related]

  • 11. Morphogenic capabilities of human immunodeficiency virus type 1 gag and gag-pol proteins in insect cells.
    Hughes BP, Booth TF, Belyaev AS, McIlroy D, Jowett J, Roy P.
    Virology; 1993 Mar 01; 193(1):242-55. PubMed ID: 8438569
    [Abstract] [Full Text] [Related]

  • 12. Differential budding efficiencies of human T-cell leukemia virus type I (HTLV-I) Gag and Gag-Pro polyproteins from insect and mammalian cells.
    Bouamr F, Garnier L, Rayne F, Verna A, Rebeyrotte N, Cerutti M, Mamoun RZ.
    Virology; 2000 Dec 20; 278(2):597-609. PubMed ID: 11118382
    [Abstract] [Full Text] [Related]

  • 13. Recombinant human immunodeficiency Pr55gag virus-like particles presenting chimeric envelope glycoproteins induce cytotoxic T-cells and neutralizing antibodies.
    Deml L, Schirmbeck R, Reimann J, Wolf H, Wagner R.
    Virology; 1997 Aug 18; 235(1):26-39. PubMed ID: 9300034
    [Abstract] [Full Text] [Related]

  • 14. Normal T cell receptor-mediated signaling in T cell lines stably expressing HIV-1 envelope glycoproteins.
    Tani Y, Tian H, Lane HC, Cohen DI.
    J Immunol; 1993 Dec 15; 151(12):7337-48. PubMed ID: 7903106
    [Abstract] [Full Text] [Related]

  • 15. Efficient human immunodeficiency virus ( HIV)-1 Gag-Env pseudovirion formation elicited from mammalian cells by a canarypox HIV vaccine candidate.
    Fang ZY, Kuli-Zade I, Spearman P.
    J Infect Dis; 1999 Oct 15; 180(4):1122-32. PubMed ID: 10479139
    [Abstract] [Full Text] [Related]

  • 16. Proteolytic activity of human immunodeficiency virus Vpr- and Vpx-protease fusion proteins.
    Wu X, Liu H, Xiao H, Kappes JC.
    Virology; 1996 May 01; 219(1):307-13. PubMed ID: 8623547
    [Abstract] [Full Text] [Related]

  • 17. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
    Kang CY, Luo L, Wainberg MA, Li Y.
    Biol Chem; 1999 Mar 01; 380(3):353-64. PubMed ID: 10223338
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Chimeric gag-V3 virus-like particles of human immunodeficiency virus induce virus-neutralizing antibodies.
    Luo L, Li Y, Cannon PM, Kim S, Kang CY.
    Proc Natl Acad Sci U S A; 1992 Nov 01; 89(21):10527-31. PubMed ID: 1438241
    [Abstract] [Full Text] [Related]

  • 20. The role of nucleocapsid of HIV-1 in virus assembly.
    Dawson L, Yu XF.
    Virology; 1998 Nov 10; 251(1):141-57. PubMed ID: 9813210
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.